Skip to content
Advertisement

Ray Hoffman, right, who is immune-compromised, is given a shot of the two-shot dose of AstraZeneca's Evusheld — the first set of antibodies grown in a lab to prevent COVID-19, Thursday, Jan. 20, 2022, by Jose Lazaro, center, a medical assistant at a University of Washington Medicine clinic in Seattle as Cynde Wiederhold, left, a nurse, looks on. The two-shot dose is supposed to give patients like Hoffman, who can't make his own virus-fighters due to taking strong immune-suppressing drugs after liver and kidney transplants, some protection against COVID-19 for six months. (AP Photo/Ted S. Warren)

Ray Hoffman, right, who is immune-compromised, is given a shot of the two-shot dose of AstraZeneca's Evusheld — the first set of antibodies grown in a lab to prevent COVID-19, Thursday, Jan. 20, 2022, by Jose Lazaro, center, a medical assistant at a University of Washington Medicine clinic in Seattle as Cynde Wiederhold, left, a nurse, looks on. The two-shot dose is supposed to give patients like Hoffman, who can't make his own virus-fighters due to taking strong immune-suppressing drugs after liver and kidney transplants, some protection against COVID-19 for six months. (AP Photo/Ted S. Warren)

Featured Photo Galleries

01-Army parade.png

Military parade celebrates Army’s 250th

Cheers and chants rang out Saturday from a crowd of thousands as soldiers manned modern and historic tanks and aircraft for the Army’s 250th anniversary celebration in the District.

20250330 Sabatini-Caps-Sabres 001.jpg

Ovi scores goal 890, Caps lose to Sabres 8-5

Alexander Ovechkin scored goal number 890, but the Washington Capitals fell short, losing to the visiting Buffalo Sabres Sunday afternoon 8-5 at Capital One Arena in Washington D.C., March 30, 2025 (Photos for the Washington Times.)